Delivery formulations

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions

Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small molecules and systemic indications.

A Better Approach, for Better Pain Trials

A Better Approach, for Better Pain Trials

Content provided by Signant Health

White Paper

Pain studies face unique challenges. For one, pain severity can only be truly assessed by the patients themselves. The controlled substances that are often used as experimental treatments in these studies bring stricter drug accountability requirements....

Transforming Clinical Development

Transforming Clinical Development

Content provided by PerkinElmer

White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical, medical device and diagnostics manufactures to identify failures early, in order to minimize costs,...

Flow Cytometry Services

Flow Cytometry Services

Content provided by Q² Solutions

Infographic

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced discovery capabilities, and the subsequent complex and comprehensive data sets required for drug...

UPLC Analysis of Methoxy & 2-Hydroxypropoxy in Hypromellose

UPLC Analysis of Methoxy & 2-Hydroxypropoxy in Hypromellose

Content provided by SGS Life Science Services

White Paper

Because of its use in the pharmaceutical and food industries, the USP has established standards relating to the amount of methoxyl and 2-hydroxypropoxyl substitutions in hypromellose. The USP...

Article on Viral Clearance for Biopharmaceuticals

Article on Viral Clearance for Biopharmaceuticals

Content provided by Catalent

White Paper

Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals.  These studies are a key component of risk mitigation to reduce the...

Customized Biosimilarity Analytical Testing from Catalent

Customized Biosimilarity Analytical Testing from Catalent

Content provided by Catalent

White Paper

Assessment of biosimilar molecules requires an orthogonal analytical approach.  Any one particular analytical technique is not able to fully define the physical and biological characteristics of...